It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Afzali reports the following financial relationships:
Advisory Board: AbbVie Inc.; Bristol Myers Squibb Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Lilly; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Consultant: AbbVie Inc.; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Lilly; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Speakers Bureau: AbbVie Inc. Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Other Financial or Material Support: IBDHorizons – Founder, Board Member and Scrubs & Heels – Founder, Board Member
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report:
- Jeffrey Helfand, DO (peer reviewer)
- Morgan Stockberger, MD (planning committee)
- John Jones, PharmD (planning committee)
- Susan H. Yarbrough, CHCP (planning committee)
- Sandra Caballero, PharmD (planning committee)
- Sharon Tordoff (planning committee)
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
